Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics

被引:11
作者
Seyyedi, Samaneh Sadat [1 ]
Soleimani, Masoud [2 ]
Yaghmaie, Marjan [3 ,4 ]
Ajami, Monireh [2 ]
Ajami, Mansoureh [2 ]
Pourbeyranvand, Shahram [5 ]
Alimoghaddam, Kamran [3 ,4 ]
Akrami, Seyed Mohammad [6 ]
机构
[1] TUMS IC, Dept Med Genet, Tehran, Iran
[2] Tarbiat Modares Univ, Sch Med Sci, Dept Hematol, Tehran, Iran
[3] Univ Tehran Med Sci, Hematol Oncol, Tehran, Iran
[4] Univ Tehran Med Sci, Stem Cell Transplantat Res Ctr, Tehran, Iran
[5] Tarbiat Modares Univ, Sch Med Sci, Dept Anat, Tehran, Iran
[6] Univ Tehran Med Sci, Dept Med Genet, Tehran, Iran
关键词
Cytogenetically normal AML; miR-1; miR-486; let-7a; MICRORNA-EXPRESSION; PERIPHERAL-BLOOD; UP-REGULATION; BONE-MARROW; GENE; DYSREGULATION; PROGNOSIS;
D O I
10.1007/s13277-015-4289-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytogenetically normal acute myeloid leukemia (CN-AML) constitutes the largest subgroup of AML patients that is associated with molecular alteration. MiRNAs have been shown to be aberrantly expressed in CN-AML. In addition, specific miRNA (miR) expression patterns were found to be associated with certain genetic alterations in these patients. This study investigated the expression level of miR-1, miR-486, and let-7a in 45 CN-AML patients well characterized for FLT3 and/or NPM1 mutations using real-time quantitative RT-PCR and evaluated the association between candidate miRs expression and clinical features. Our data revealed that miR-1 was significantly overexpressed in CN-AML patients, and increasing expression of miR-1 correlated with NPM1 mutation (P < 0.05) and lower hemoglobin level was also observed in patients with miR-1 overexpression (P < 0.05). The expression of miR-1 was much higher in AML-M2 compared with other subtypes. Further, we found significantly increasing miR-486 expression in 40 of 45 (89 %) CN-AML patients. There was no significant association of upregulation of miR-486 with clinical parameters. The expression level of miR-486 was increased in AML-M2 subtype. The levels of let-7a were significantly increased in CN-AML patients compared to the healthy control and significantly higher in the NPM1 +/- CN-AML patients. There was no correlation detected between the level of let-7a and FLT3+. An increasing expression level of let-7a was demonstrated in M2 subtype. In addition, our data showed no significant association between increasing let-7a and clinical characteristic. Comparison of peripheral blood and bone marrow results in 30 CN-AML patients showed that there is a considerable concordance between PB and BM in the results of candidate miR levels (P < 0.001). In conclusion, further studies should also be performed to detect functional mechanism of these miRs.
引用
收藏
页码:4841 / 4847
页数:7
相关论文
共 33 条
[1]   Molecular genetics in acute myeloid leukemia [J].
Bacher, Ulrike ;
Schnittger, Susanne ;
Haferlach, Torsten .
CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) :646-655
[2]   Detection of Nucleophosmin 1 Mutations by Quantitative Real-Time Polymerase Chain Reaction Versus Capillary Electrophoresis A Comparative Study [J].
Barakat, Fareed H. ;
Luthra, Rajyalakshmi ;
Yin, Cameron ;
Barkoh, Bedia A. ;
Hai, Seema ;
Jamil, Waqar ;
Bhakta, Yaminiben I. ;
Chen, Su ;
Medeiros, L. Jeffrey ;
Zuo, Zhuang .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (08) :994-1000
[3]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study [J].
Becker, Heiko ;
Marcucci, Guido ;
Maharry, Kati ;
Radmacher, Michael D. ;
Mrozek, Krzysztof ;
Margeson, Dean ;
Whitman, Susan P. ;
Wu, Yue-Zhong ;
Schwind, Sebastian ;
Paschka, Peter ;
Powell, Bayard L. ;
Carter, Thomas H. ;
Kolitz, Jonathan E. ;
Wetzler, Meir ;
Carroll, Andrew J. ;
Baer, Maria R. ;
Caligiuri, Michael A. ;
Larson, Richard A. ;
Bloomfield, Clara D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :596-604
[6]  
Bryant A, 2012, MOL CANCER, V11, P1476
[7]   Dysregulation of miR-124-1 predicts favorable prognosis in acute myeloid leukemia [J].
Chen, Xing-xing ;
Lin, Jiang ;
Qian, Jun ;
Qian, Wei ;
Yang, Jing ;
Ma, Ji-chun ;
Deng, Zhao-qun ;
Xie, Dong ;
An, Cui ;
Tang, Chun-yan ;
Qian, Zhen .
CLINICAL BIOCHEMISTRY, 2014, 47 (1-2) :63-66
[8]   CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia [J].
Chen, Ye ;
Jacamo, Rodrigo ;
Konopleva, Marina ;
Garzon, Ramiro ;
Croce, Carlo ;
Andreeff, Michael .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06) :2395-2407
[9]  
Deeb Kristin K, 2014, Leuk Res Rep, V3, P86, DOI 10.1016/j.lrr.2013.09.003
[10]   MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status [J].
Faraoni, Isabella ;
Laterza, Serena ;
Ardiri, Davide ;
Ciardi, Claudia ;
Fazi, Francesco ;
Lo-Coco, Francesco .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5